PPMI at AD/PD 2015

PPMI is proud to be well-represented at the 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2015).  The conference is being held March 18-22 in Nice, France and focuses on building an understanding of Alzheimer’s and Parkinson’s and the similarities between them as well as advancing treatments for such disorders.  Notable talks involving PPMI data include:

Wednesday, March 18

9:50am – PREDICTION OF PARKINSON?S DISEASE PROGRESSION USING DIFFUSION TENSOR IMAGING – Speaker: Norbert Schuff

Thursday, March 19

4:05pm – ACCURATE, NON-INVASIVE AND LOW COST PREDICTIVE MODEL FOR PD  – Speaker: Mike Nalls

5:15pm – THE PARKINSON?S PROGRESSION MARKER INITIATIVE ? DEVELOPING TRANSLATIONAL TOOLS TO ACCELERATE PD THERAPIES – Speaker: Ken Marek

Saturday. March 21

10:20am – BIOMARKERS FOR ALPHA-SYNUCLEIN THERAPEUTIC TRIALS – Speaker: Mark Frasier

10:55am – PROGRESSION OF WHITE MATTER DEGENERATION IN EARLY PD: A MULTICENTER EVALUATION USING DIFFUSION TENSOR IMAGING  – Speaker: Yu Zhang

Sunday, March 22

9:35am – LONGITUDINAL PD BIOMARKER STUDIES: DENOPA AND PPMI – Speaker: Brit Mollenhauer

For more information about the conference, including a full program, please visit AD/PD 2015.